Endpoint definition
↥| Name | E4_AMYL_ORGAN |
|---|---|
| Long name | Organ-limited amyloidosis |
| Hospital Discharge registry | ICD-10: E854 |
| Cause of Death registry | ICD-10: E854 |
| Level in the ICD-hierarchy | 4 |
| First defined in version | DF2 |
| Latin name | Amyloidosis in uno organo |
Organ-limited amyloidosis
amyloidosis: A disorder characterized by the localized or diffuse accumulation of amyloid protein in various anatomic sites. It may be primary, due to clonal plasma cell proliferations; secondary, due to long standing infections, chronic inflammatory disorders, or malignancies; or familial. It may affect the nerves, skin, tongue, joints, heart, liver, spleen, kidneys and adrenal glands.
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 36 | 16 | 20 |
| Unadjusted prevalence (%) | 0.02 | 0.01 | 0.02 |
| Mean age at first event (years) | 69.11 | 65.13 | 72.29 |
| Case fatality at 5-years (%) | 55.56 | 37.50 | 70.00 |
Longitudinal metrics
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 1.0 | 1.0 | 1.0 |
| Recurrence at 6 months (%) | 25.00 | 31.25 | 20.00 |
Survival analyses between endpoints
↥Plot
before Organ-limited amyloidosis
after Organ-limited amyloidosis
Loading survival analyses plot…
Table
Loading survival analyses table…